Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Exchange Rate Effect (2016 - 2025)

Integra Lifesciences Holdings' Exchange Rate Effect history spans 16 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 119.83% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $18.0 million, up 378.73%, while the annual FY2025 figure was $18.0 million, 378.73% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $1.6 million at Integra Lifesciences Holdings, up from -$801000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $12.7 million in Q2 2025 and bottomed at -$10.7 million in Q3 2022.
  • The 5-year median for Exchange Rate Effect is -$507000.0 (2023), against an average of -$237850.0.
  • The largest annual shift saw Exchange Rate Effect crashed 629.67% in 2024 before it surged 1226.93% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at $904000.0 in 2021, then soared by 1217.37% to $11.9 million in 2022, then crashed by 32.5% to $8.0 million in 2023, then tumbled by 201.04% to -$8.1 million in 2024, then soared by 119.83% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for IART's Exchange Rate Effect are $1.6 million (Q4 2025), -$801000.0 (Q3 2025), and $12.7 million (Q2 2025).